热门资讯> 正文
Lantheus退出,重新提交HSR收购Curium的申请
2026-09-22 05:35
- Lantheus Holdings (LNTH) said it has withdrawn and refiled its Hart-Scott-Rodino (HSR) Act pre-merger notification regarding its $8B acquisition of Curium.
- The withdrawal, done on Sept. 17, was done "to provide the Federal Trade Commission (the “FTC”) with additional time to review the Merger," per an SEC filing.
- The resubmission was filed on Monday, meaning the standard HSR 30-day waiting period will end on Oct. 21 at 11:59 p.m.
- Lantheus said that a refiling is “routine procedure” for antitrust review and still expects the merger to close in H1 2027.
More on Lantheus Holdings
- Lantheus Holdings: Why I Am Exiting Before The Merger Closes
- Novartis' Lutathera now facing generic competition from Curium's Bexlutry
- Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s
- Seeking Alpha’s Quant Rating on Lantheus Holdings
- Historical earnings data for Lantheus Holdings
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。